Skip to content
GLP-1 Scorecard
Menu
Site position #114

TRYM Health

Published by GLP-1 ScorecardUpdated

TRYM Health (TRYM) is a nationwide telehealth service offering compounded GLP-1 weight-loss medication — semaglutide (~$96/mo, $3.20/day) and tirzepatide (~$126/mo, $4.20/day) — as additive-free multi-dose vials covering all doses, with a starter kit, temperature-controlled shipping, FSA/HSA eligibility, and flexible cancellation.

Visit TRYM HealthWe may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Semaglutide
$96/mo (all doses, compounded)
Tirzepatide
$126/mo (all doses, compounded)
Coverage
Coverage not published
Brand-name
Not confirmed

Weigh TRYM Health against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. If you are considering a compounded option, read about whether compounded semaglutide is legit and safe.

Factor breakdown

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.

Cost value96/100
Dose & formulation72/100
Clinical oversight55/100
Labs & monitoring53/100
Fulfillment74/100
Contract terms55/100

Strengths

  • Affordable compounded GLP-1 — semaglutide ~$96/mo ($3.20/day) and tirzepatide ~$126/mo ($4.20/day)
  • Available in all 50 states with free shipping and FSA/HSA eligibility
  • Multi-dose vials cover all doses up to the maximum; additive-free, with a full starter kit
  • Temperature-controlled insulated shipping and flexible cancellation

What to consider

  • Compounding pharmacy partner not named
  • LegitScript certification was not documented on the public pages reviewed
  • Lowest per-day pricing likely requires a longer prepaid plan commitment
  • Drugs labeled generically as 'GLP-1' / 'GLP-1 + GIP' on the services page rather than named
  • FDA issued TRYM Health, Inc. dba TRYM Health a warning letter in September 2025; the letter is public in FDA's warning-letter database

Bottom line — Grade C

Best for: Budget-focused shoppers wanting low-cost compounded GLP-1 vials shipped nationwide.

Site position #114 of 541. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

FDAWarning letter issued to TRYM Health, Inc. dba TRYM Health in September 2025. See the FDA warning-letter database.

Closest here

The rankings grading nearest TRYM Health — the realistic shortlist.

The 21 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect TRYM Health's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on TRYM Health's site. Not medical advice; see our disclosure.

← Back to the scorecard